Devon, United Kingdom

Julian R Smith


Average Co-Inventor Count = 10.6

ph-index = 3

Forward Citations = 286(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Julian R. Smith

Introduction

Julian R. Smith is a notable inventor based in Devon, GB, recognized for his significant contributions to the field of pharmacology and receptor modulation. With a total of three patents to his name, his work primarily focuses on the development of novel compounds that interact with serotonin receptors, showing promise in various therapeutic applications.

Latest Patents

Among his latest innovations, Smith has developed patents such as "Small molecule modulators of non-endogenous, constitutively activated," which discloses non-endogenous, constitutively activated forms of the human 5-HT2A and human 5-HT2C receptors. This patent includes methods for screening candidate compounds that act specifically on these receivers. Additionally, his work details a new class of compounds that target the 5-HT2A receptors, enhancing the understanding and potential treatment options related to these significant receptors in the human body. Another notable patent is focused on a compound of formula (C) that serves as a serotonin receptor modulator, further expanding the scope and application of his research.

Career Highlights

Julian R. Smith has made substantial strides in his career, having worked with reputable companies such as Arena Pharmaceuticals, Inc. and Tripos, Inc. His experiences in these organizations have bolstered his expertise in drug discovery and development, allowing him to innovate within the biopharmaceutical industry.

Collaborations

Throughout his career, Smith has collaborated with distinguished colleagues, including Dominic P. Behan and Derek T. Chalmers. These partnerships have been instrumental in facilitating his research endeavors, enabling the cross-pollination of ideas that lead to innovative solutions in serum receptor modulation.

Conclusion

In conclusion, Julian R. Smith stands out as an inventive force in the realm of pharmacology. His patents reflect a deep understanding of serotonin receptors and showcase his ability to develop practical applications that could revolutionize therapeutic strategies. With a firm foundation in collaborative research and a commitment to innovation, he continues to play a crucial role in advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…